Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma. Grill, J.; Massimino, M.; Bouffet, E.; Azizi, A. A.; McCowage, G.; Canete, A.; Saran, F.; Le Deley, M. C.; Varlet, P.; Morgan, P. S.; Jaspan, T.; Jones, C.; Giangaspero, F.; Smith, H.; Garcia, J.; Elze, M. C.; Rousseau, R. F.; Abrey, L.; Hargrave, D.; Vassal, G.. J Clin Oncol. 2018; 951-958: p.951-958. doi:10.1200/JCO.2017.76.0611Article
Oncostat